BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25650288)

  • 21. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
    Farr DE; Thomas A; Khan SA; Schroeder MC
    Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk of second malignancies after in situ breast carcinoma in a population-based registry.
    Soerjomataram I; Louwman WJ; van der Sangen MJ; Roumen RM; Coebergh JW
    Br J Cancer; 2006 Aug; 95(3):393-7. PubMed ID: 16804522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Race, ethnicity and risk of second primary contralateral breast cancer in the United States.
    Watt GP; John EM; Bandera EV; Malone KE; Lynch CF; Palmer JR; Knight JA; Troester MA; Bernstein JL
    Int J Cancer; 2021 Jun; 148(11):2748-2758. PubMed ID: 33544892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ.
    Robinson D; Holmberg L; Møller H
    Br J Cancer; 2008 Aug; 99(4):611-5. PubMed ID: 18665169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Other Primary Malignancies Among Women With Adult-Type Ovarian Granulosa Cell Tumors.
    Bryk S; Pukkala E; Färkkilä A; Heikinheimo M; Unkila-Kallio L; Riska A
    Int J Gynecol Cancer; 2018 Oct; 28(8):1529-1534. PubMed ID: 30036228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
    Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer.
    Kwast AB; Liu L; Roukema JA; Voogd AC; Jobsen JJ; Coebergh JW; Soerjomataram I; Siesling S
    Br J Cancer; 2012 Jul; 107(3):549-55. PubMed ID: 22713658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second primary cancers in breast cancer patients in Slovenia.
    Volk N; Pompe-Kirn V
    Cancer Causes Control; 1997 Sep; 8(5):764-70. PubMed ID: 9328199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for the incidence of breast cancer: do they affect survival from the disease?
    Barnett GC; Shah M; Redman K; Easton DF; Ponder BA; Pharoah PD
    J Clin Oncol; 2008 Jul; 26(20):3310-6. PubMed ID: 18612147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen and risk of large bowel cancer in women with breast cancer.
    Newcomb PA; Solomon C; White E
    Breast Cancer Res Treat; 1999 Feb; 53(3):271-7. PubMed ID: 10369073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer risk in women with previous breast cancer.
    Levi F; Te VC; Randimbison L; La Vecchia C
    Ann Oncol; 2003 Jan; 14(1):71-3. PubMed ID: 12488295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
    Abhyankar N; Hoskins KF; Abern MR; Calip GS
    BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer risk after radiotherapy for breast cancer.
    Levi F; Randimbison L; Te VC; La Vecchia C
    Br J Cancer; 2006 Aug; 95(3):390-2. PubMed ID: 16804519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
    Cluze C; Delafosse P; Seigneurin A; Colonna M
    Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second primary gynecologic cancers after breast cancer in Turkish women.
    Gulhan I; Eser S; Yakut C; Bige O; Ilhan E; Yildirim Y; Saygili U
    Int J Gynecol Cancer; 2009 May; 19(4):648-50. PubMed ID: 19509564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second primary in the contralateral breast after treatment of breast cancer.
    Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor RK
    Radiother Oncol; 2008 Feb; 86(2):171-6. PubMed ID: 17961777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifestyle factors and the risk of a second breast cancer after ductal carcinoma in situ.
    McLaughlin VH; Trentham-Dietz A; Hampton JM; Newcomb PA; Sprague BL
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):450-60. PubMed ID: 24403528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiologic and molecular risk factors for contralateral breast cancer among young women.
    Li CI; Malone KE; Porter PL; Daling JR
    Br J Cancer; 2003 Aug; 89(3):513-8. PubMed ID: 12888823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.